Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Belldegrun

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluidA Belldegrun, A Kasid, M Uppenkamp, et al.
Cancer Surveys|January 1, 1995
Gene therapy: principles and potentialS S Taneja, S Pang, P Cohan, et al.
The Urologic Clinics of North America|November 1, 1994
Management of disseminated kidney cancerS S Taneja, W Pierce, R Figlin, et al.
Urology|June 1, 1995
Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatmentS S Taneja, W Pierce, R Figlin, et al.
The Journal of Urology|June 24, 1999
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapyJ Naitoh, A Kaplan, F Dorey, et al.
Urology|August 5, 2000
Incidental renal tumorsA J Pantuck, A Zisman, M K Rauch, et al.
Reviews in Urology|September 21, 2006
Nephron-sparing surgery for renal cell carcinomaK H Tsui, A van Ophoven, O Shvarts, et al.
Reviews in Urology|September 21, 2006
Thyroid autoantibodies, telomerase activity, vascular endothelial growth factor, and bone scanningA van Ophoven, B Patel, M K Rauch, et al.
British Journal of Urology|August 1, 1987
Transurethral incisions and resections under local anaesthesiaK R Loughlin, S V Yalla, A Belldegrun, et al.
Seminars in Oncology|April 18, 2000
Adoptive cellular therapyD M Hoffman, B J Gitlitz, A Belldegrun, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Lymphokine mRNA profile and functional analysis of a human CD4+ clone with unique antitumor specificity isolated from renal cell carcinoma ascitic fluidA Belldegrun, A Kasid, M Uppenkamp, et al.
Cancer Surveys|January 1, 1995
Gene therapy: principles and potentialS S Taneja, S Pang, P Cohan, et al.
The Urologic Clinics of North America|November 1, 1994
Management of disseminated kidney cancerS S Taneja, W Pierce, R Figlin, et al.
Urology|June 1, 1995
Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatmentS S Taneja, W Pierce, R Figlin, et al.
The Journal of Urology|June 24, 1999
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapyJ Naitoh, A Kaplan, F Dorey, et al.
Urology|August 5, 2000
Incidental renal tumorsA J Pantuck, A Zisman, M K Rauch, et al.
Reviews in Urology|September 21, 2006
Nephron-sparing surgery for renal cell carcinomaK H Tsui, A van Ophoven, O Shvarts, et al.
Reviews in Urology|September 21, 2006
Thyroid autoantibodies, telomerase activity, vascular endothelial growth factor, and bone scanningA van Ophoven, B Patel, M K Rauch, et al.
British Journal of Urology|August 1, 1987
Transurethral incisions and resections under local anaesthesiaK R Loughlin, S V Yalla, A Belldegrun, et al.
Seminars in Oncology|April 18, 2000
Adoptive cellular therapyD M Hoffman, B J Gitlitz, A Belldegrun, et al.
Pageof 13